ANDA 85734, held by B. Braun Medical. Ammonium Chloride.
As of Nov 21, 2026, ANDA 85734 (Ammonium Chloride 2.14%), held by B. Braun Medical, was first approved by FDA on Oct 13, 1978, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 13, 1978 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ammonium Chloride 2.14%40MEQ/100ML · injectable;injection | Ammonium Chloride | Discontinued |
| May 5, 1986 | Supplement 9Manufacturing | Approved | None posted |
| Apr 29, 1983 | Supplement 4Manufacturing | Approved | None posted |
| Dec 29, 1982 | Supplement 5Manufacturing | Approved | None posted |
| Jun 4, 1982 | Supplement 3Manufacturing | Approved | None posted |
| Oct 13, 1978 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters